{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Épilepsie partielle complexe : Questions médicales les plus fréquentes",
"headline": "Épilepsie partielle complexe : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Épilepsie partielle complexe : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-30",
"dateModified": "2025-04-24",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Épilepsie partielle complexe"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Épilepsies partielles",
"url": "https://questionsmedicales.fr/mesh/D004828",
"about": {
"@type": "MedicalCondition",
"name": "Épilepsies partielles",
"code": {
"@type": "MedicalCode",
"code": "D004828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C10.228.140.490.360"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Épilepsie partielle complexe",
"alternateName": "Epilepsy, Complex Partial",
"code": {
"@type": "MedicalCode",
"code": "D017029",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "None None",
"url": "https://questionsmedicales.fr/author/None%20None",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Xiao-Rong Liu",
"url": "https://questionsmedicales.fr/author/Xiao-Rong%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Yong-Hong Yi",
"url": "https://questionsmedicales.fr/author/Yong-Hong%20Yi",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Jie Wang",
"url": "https://questionsmedicales.fr/author/Jie%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
},
{
"@type": "Person",
"name": "Wei-Ping Liao",
"url": "https://questionsmedicales.fr/author/Wei-Ping%20Liao",
"affiliation": {
"@type": "Organization",
"name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Evaluation of the efficacy and safety of ionic liquids containing ketoconazole in patients with tinea pedis: A randomized controlled clinical trial.",
"datePublished": "2022-12-02",
"url": "https://questionsmedicales.fr/article/37206222",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/btm2.10463"
}
},
{
"@type": "ScholarlyArticle",
"name": "Low utilization of confirmatory testing for tinea capitis by pediatricians at an academic center in New York, United States, 2005-2021.",
"datePublished": "2023-11-17",
"url": "https://questionsmedicales.fr/article/38046680",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fped.2023.1297339"
}
},
{
"@type": "ScholarlyArticle",
"name": "Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study.",
"datePublished": "2023-08-24",
"url": "https://questionsmedicales.fr/article/37620517",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/myc.13651"
}
},
{
"@type": "ScholarlyArticle",
"name": "Analysis of optimal control strategies on the fungal Tinea capitis infection fractional order model with cost-effective analysis.",
"datePublished": "2024-01-17",
"url": "https://questionsmedicales.fr/article/38233520",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-024-51670-y"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neglected Adult Tinea Capitis in South China: A Retrospective Study in Nanchang, Jiangxi Province, from 2007 to 2021.",
"datePublished": "2023-05-09",
"url": "https://questionsmedicales.fr/article/37160498",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11046-023-00736-y"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies du système nerveux",
"item": "https://questionsmedicales.fr/mesh/D009422"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies du système nerveux central",
"item": "https://questionsmedicales.fr/mesh/D002493"
},
{
"@type": "ListItem",
"position": 4,
"name": "Encéphalopathies",
"item": "https://questionsmedicales.fr/mesh/D001927"
},
{
"@type": "ListItem",
"position": 5,
"name": "Épilepsie",
"item": "https://questionsmedicales.fr/mesh/D004827"
},
{
"@type": "ListItem",
"position": 6,
"name": "Épilepsies partielles",
"item": "https://questionsmedicales.fr/mesh/D004828"
},
{
"@type": "ListItem",
"position": 7,
"name": "Épilepsie partielle complexe",
"item": "https://questionsmedicales.fr/mesh/D017029"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Épilepsie partielle complexe - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Épilepsie partielle complexe",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-19",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Épilepsie partielle complexe",
"description": "Comment diagnostique-t-on l'épilepsie partielle complexe ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes symptômes peuvent-ils varier d'un patient à l'autre ?\nQuel rôle joue l'historique médical dans le diagnostic ?\nPeut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=14#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Épilepsie partielle complexe",
"description": "Quels sont les symptômes typiques des crises ?\nLes crises peuvent-elles affecter la mémoire ?\nComment se manifestent les comportements automatisés ?\nLes crises peuvent-elles être précédées d'aura ?\nLes symptômes peuvent-ils persister après la crise ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=14#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Épilepsie partielle complexe",
"description": "Peut-on prévenir les crises d'épilepsie partielle complexe ?\nQuels sont les déclencheurs courants des crises ?\nL'éducation des proches est-elle importante ?\nLes activités physiques sont-elles sûres ?\nComment gérer le stress pour prévenir les crises ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=14#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Épilepsie partielle complexe",
"description": "Quels médicaments sont couramment prescrits ?\nLa chirurgie est-elle une option de traitement ?\nQuelles sont les alternatives aux médicaments ?\nComment évaluer l'efficacité du traitement ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=14#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Épilepsie partielle complexe",
"description": "Quelles sont les complications possibles de l'épilepsie ?\nL'épilepsie peut-elle affecter la vie sociale ?\nY a-t-il un risque accru de dépression ?\nLes crises peuvent-elles entraîner des blessures graves ?\nComment les complications peuvent-elles être gérées ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=14#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Épilepsie partielle complexe",
"description": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?\nL'âge influence-t-il le risque d'épilepsie ?\nLes maladies neurologiques augmentent-elles le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe stress peut-il être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D017029?mesh_terms=Tinea&page=14#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on l'épilepsie partielle complexe ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique médical, l'EEG et l'imagerie cérébrale."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'EEG et l'IRM sont essentiels pour visualiser l'activité cérébrale et les anomalies."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils varier d'un patient à l'autre ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent différer selon la localisation de l'activité épileptique."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à identifier les antécédents de crises et les facteurs déclenchants."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer l'épilepsie partielle complexe chez les enfants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut se manifester chez les enfants, nécessitant une évaluation spécialisée."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes typiques des crises ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des mouvements involontaires, des hallucinations et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles affecter la mémoire ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les crises peuvent entraîner des pertes de mémoire temporaires ou des confusions."
}
},
{
"@type": "Question",
"name": "Comment se manifestent les comportements automatisés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les comportements automatisés incluent des gestes répétitifs sans conscience de l'environnement."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles être précédées d'aura ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes ressentent une aura, un signe avant-coureur de la crise."
}
},
{
"@type": "Question",
"name": "Les symptômes peuvent-ils persister après la crise ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la fatigue ou la confusion peuvent persister après la crise."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les crises d'épilepsie partielle complexe ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il soit difficile de prévenir, éviter les déclencheurs connus peut aider."
}
},
{
"@type": "Question",
"name": "Quels sont les déclencheurs courants des crises ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress, le manque de sommeil et l'alcool sont des déclencheurs fréquents."
}
},
{
"@type": "Question",
"name": "L'éducation des proches est-elle importante ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, informer les proches sur les crises et les premiers secours est crucial."
}
},
{
"@type": "Question",
"name": "Les activités physiques sont-elles sûres ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines activités peuvent être sûres, mais il est important de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir les crises ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de relaxation comme la méditation peuvent aider à gérer le stress."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment prescrits ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticonvulsivants comme la carbamazépine et la lamotrigine sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la chirurgie peut être envisagée si les médicaments ne contrôlent pas les crises."
}
},
{
"@type": "Question",
"name": "Quelles sont les alternatives aux médicaments ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les thérapies comportementales et la stimulation cérébrale peuvent être des options."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité du traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par la fréquence des crises et les effets secondaires des médicaments."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain, incluant sommeil et gestion du stress, peut aider."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de l'épilepsie ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent les blessures lors des crises et des problèmes psychologiques."
}
},
{
"@type": "Question",
"name": "L'épilepsie peut-elle affecter la vie sociale ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des difficultés sociales et des stigmates associés."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de dépression ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes épileptiques présentent un risque plus élevé de dépression et d'anxiété."
}
},
{
"@type": "Question",
"name": "Les crises peuvent-elles entraîner des blessures graves ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les chutes ou les accidents pendant une crise peuvent causer des blessures graves."
}
},
{
"@type": "Question",
"name": "Comment les complications peuvent-elles être gérées ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une prise en charge multidisciplinaire est essentielle pour gérer les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de l'épilepsie partielle complexe ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, les traumatismes crâniens et les infections cérébrales sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'épilepsie ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'épilepsie peut survenir à tout âge, mais elle est plus fréquente chez les jeunes enfants et les personnes âgées."
}
},
{
"@type": "Question",
"name": "Les maladies neurologiques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme la sclérose en plaques peuvent augmenter le risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme l'exposition à des toxines peuvent contribuer au risque d'épilepsie."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut déclencher des crises chez certaines personnes épileptiques."
}
}
]
}
]
}
Ionic liquids (ILs) loading ketoconazole (KCZ) have shown better efficacy on rats with tinea pedis than the marketed Daktarin® but clinical studies are still lacking. In this study, we described the c...
We retrospectively reviewed physician diagnostic and treatment practices for pediatric tinea capitis at an academic institution over 16 years, in assessing adherence with published guidelines. We demo...
Tinea capitis (TC), a fungal infection that occurs in children, is primarily caused by dermatophytes such as Trichophyton and Microsporum species. For Trichophyton species, treatment with terbinafine ...
This study aimed to describe and compare the response to treatment among Israeli and refugee children with TC....
We retrospectively reviewed data collected on refugee and Israeli children with TC between January 2004 and January 2020....
Overall, 3358 children with TC (refugees: 1497; Israelis: 1861) were identified. Among these, 86% of the refugee children had TC caused by Trichophyton violaceum, 65% of the Israeli children had TC ca...
The over-crowded day care centres and dense living make refugee children more susceptible to TC than the general population, and griseofulvin dosage adjustment is necessary. TC, due to Trichophyton sp...
In this study, we have formulated and analyzed the Tinea capitis infection Caputo fractional order model by implementing three time-dependent control measures. In the qualitative analysis part, we inv...
Tinea capitis (TC) in adults is much less frequently diagnosed in comparison to TC in children. In this study, we explored retrospectively adult TC in a specialized dermatology hospital, located in So...
Very limited data on tinea genitalis, a potentially severe dermatophytosis transmitted during sexual intercourse affecting the genital area, suggest its potential to cause outbreaks. Thus, we investig...
BB2603 is a nano-formulation of the antifungal drug terbinafine with the polymer polyhexamethylene biguanide (PHMB) as an excipient to enhance solubility and drug delivery to skin and nails. BB2603 is...
Introduction/Objective In Morocco, tinea capitis is a common reason for consultation, especially in children. Our study aimed to determine the epidemiology of tinea capitis in the Central Laboratory o...
Owing to pharmacokinetic challenges of itraconazole, super-bioavailable itraconazole (SB) was developed and recently approved in strengths of 50mg and 65mg. But comparative study was lacking between t...
One hundred eligible patients were enrolled in this prospective, randomized, clinical study during May-2022 to September-2022 at tertiary hospital in Ahmedabad in adults. Efficacy and safety assessmen...
Of the 100 patients enrolled, 98 patients (50 in SB-50mg and 48 in SB-65mg group) included in the final analysis. At week 6, 20 patients (40%) and 30 patients (62.5%) achieved complete cure (p < 0.05)...
Study result concluded the superiority of SB-65mg over SB-50mg in terms of cure rate and resolution of symptoms in dermatophytosis management....
Tinea incognita (TI) can mimic other dermatoses, presenting a diagnostic challenge for dermatologists. In some uncertain cases, it is crucial to accurately identify the causative agent using internal ...